| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |